If it doesn't? Well, we won't know that for another month. And that's how it will go.
Some Stocks Are Just Too Dangerous
Posted at 6:37 p.m. EDT on Thursday, Dec. 20
I've got not one, not two but three cautionary tales about what happens when you wander into battlegrounds, obvious battlegrounds that can be avoided.In fact, today's action provides a battlefield manual of where not to go, where the interstitial machine gunfire is so overwhelming that you know you are going to eat lead. We've got three companies, Mellanox Technologies (MLNX - Get Report), Allscripts Healthcare Solutions (MDRX - Get Report) and Herbalife (HLF - Get Report), all vying for worst battlefields out there. Let's start with Mellanox Technologies. Here's one I put in the "sell block" a few months back, after it caught a gigantic gain. The Israeli semiconductor company had had a monster run. Next thing I know, the chief financial officer retired, and I thought it had just moved up too much, so I just said "enough already." Sure enough, Mellanox reported soon after, and it didn't have the best guidance, so I told people here to dump it. I said that while you can never get out at the top, I thought that once the stock was broken, it would stay broken. And that's just what happened. There are some obvious lessons here. When a CFO departs, even if the move is orderly, it is worth it to ring the register particularly, after a colossal run. Then once a red-hot stock reports a weak quarter, it doesn't pay to hang around, as the momentum people will sell relentlessly. That's what is happening in today's action. Then there's Allscripts Healthcare solutions, another hammered stock today. Allscripts, another "sell block" name, had faltered badly and lost out to Cerner (CERN) for a lot of business. I had urged people to bolt from it, but the CEO of Allscripts, Glen Tullman, tried to sell the company. I say over and over again that you can't speculate on a takeover if the fundamentals are in decline as they were with Allscripts, because who wants to buy a faltering business? Apparently no one; Tullman was fired last night.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV